PedAM
Pediatric Disease Annotations & Medicines
| Disease | artery disease |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 75 |
| PubMedID- 23042402 | Objective: to assess the role of small ubiquitin-like modifier 4 (sumo4) gene polymorphisms (rs237025, rs237024 and rs600739) in the susceptibility to coronary artery disease (cad) with and without type 2 diabetes mellitus (t2dm) in chinese han ethnic population in beijing. |
| PubMedID- 22553938 | Su et al [26] studied glycaemic variability determined by a continuous 72-hours glucose monitoring system and the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24667131 | Reported the coronary angiography data suggesting that small chylomicron remnants were implicated in the progression of coronary artery diseases in patients with type 2 diabetes mellitus [26]. |
| PubMedID- 26247098 | Risk of developing coronary artery disease in patients with type 2 diabetes receiving traditional chinese medicine therapy. |
| PubMedID- 26184866 | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. |
| PubMedID- 23433938 | Lox-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes. |
| PubMedID- 22276258 | Screening for coronary artery disease in patients with type 2 diabetes mellitus: an evidence-based review. |
| PubMedID- 21438666 | Association of pon1 and apoa5 gene polymorphisms in a cohort of indian patients having coronary artery disease with and without type 2 diabetes. |
| PubMedID- 24396666 | A1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c levels greater than 7. |
| PubMedID- 24396702 | However, effect of hba1c variability on coronary artery disease in type 2 diabetes was not described, especially when using such a sensitive diagnostic method like coronary angiography, as in the article by lee et al. |
| PubMedID- 26521236 | Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study. |
| PubMedID- 25380532 | Cardiac outcomes 3 years after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: value of myocardial perfusion imaging and coronary calcium score. |
| PubMedID- 21968503 | Objective: an increased expression of plasminogen activator inhibitor type-1 (pai-1) has been implicated in accelerating atherogenesis and coronary artery disease in patients with type 2 diabetes. |
| PubMedID- 26265234 | Investigation of mda-ldl (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25931789 | Association between serum fibroblast growth factor 21 and coronary artery disease in patients with type 2 diabetes. |
| PubMedID- 25042974 | [prevalence and factors associated with peripheral artery disease in patients with type 2 diabetes mellitus in primary care]. |
| PubMedID- 20446572 | We have shown the combination of two atherosclerosis-prone snps highly significantly contribute to carotid atherosclerosis and coronary artery disease in subjects with type 2 diabetes. |
| PubMedID- 22138970 | G1359a polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes. |
| PubMedID- 23018602 | Objectives: this study aimed to compare the value of serum glycated albumin (ga) level versus glycated hemoglobin a(1c) (hba(1c)) for evaluating the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23597770 | Patients with type 2 diabetes mellitus without evidence of coronary artery disease were recruited. |
| PubMedID- 24049616 | Background: chronic kidney disease (ckd) coexisting with type 2 diabetes mellitus (dm) leads to coronary artery disease. |
| PubMedID- 26451069 | Association of plasma myeloperoxidase level with risk of coronary artery disease in patients with type 2 diabetes. |
| PubMedID- 25060531 | Peripheral artery disease in patients with type 2 diabetes. |
| PubMedID- 23316958 | On the contrary, the association between intraday glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes has been studied by su et al. |
| PubMedID- 21400095 | Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes. |
| PubMedID- 24295032 | Objective: to evaluate possible associations between cardiovascular autonomic dysfunction and peripheral artery disease (pad) in patients with type 2 diabetes mellitus. |
| PubMedID- 25031198 | Introduction: newly diagnosed type 2 diabetes mellitus (t2dm) in patients with coronary artery disease (cad) more than doubles the risk of death compared with otherwise matched glucose tolerant patients. |
| PubMedID- 21930272 | Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes. |
| PubMedID- 21922009 | Purpose: the incidence of cardiovascular events is higher in coronary artery disease patients with type 2 diabetes (cad + t2d) than in cad patients without t2d. |
| PubMedID- 22048611 | The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23391668 | Coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm) is associated with increased immediate and long-term mortality compared with patients without t2dm. |
| PubMedID- 23031065 | Effects of exercise prescription on daily physical activity and maximal exercise capacity in coronary artery disease patients with and without type 2 diabetes. |
| PubMedID- 24282409 | Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. |
| PubMedID- 26355919 | Carotid artery disease in patients with type 2 diabetes. |
| PubMedID- 24273550 | Decreased mirna-126 was also found in atherosclerotic coronary artery disease (cad) and in patients with type 2 diabetes mellitus and may reflect the condition of vascular endothelial cells in heart failure patients (fukushima et al., 2011). |
| PubMedID- 24396703 | Response: a1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c level greater than 7 (endocrinol metab 2013;28:125-32, eun ju lee et al.) |
| PubMedID- 23343465 | Coronary artery disease (cad) concomitant with type 2 diabetes (t2d) is the leading cause of cardiovascular (cv) morbidity and mortality. |
| PubMedID- 23153979 | This study determined the role of endothelial nitric oxide synthase (enos) glu298asp polymorphism and intergenotypic variation of plasma nitric oxide (no) levels in coronary artery disease (cad) patients with type 2 diabetes mellitus (dm). |
| PubMedID- 21349201 | The objective of this study was to assess the relationship between glycemic variability determined by a continuous glucose monitoring (cgm) system and the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24589558 | Simple exercise test score versus cardiac stress test for the prediction of coronary artery disease in patients with type 2 diabetes. |
| PubMedID- 21386092 | Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. |
| PubMedID- 22162951 | This work also sheds light on the interplay of genetic and environmental factors that cause metabolic syndrome in people, which is characterized by obesity and insulin resistance, and increases the risks of stroke and coronary artery disease along with type 2 diabetes. |
| PubMedID- 23959565 | Determinants and prognostic value of cardiovascular autonomic function in coronary artery disease patients with and without type 2 diabetes. |
| PubMedID- 21911782 | Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial. |
| PubMedID- 22661969 | In the bari 2d trial of therapies for type 2 diabetes in patients with coronary artery disease, treatment approaches based on use of su and/or insulin were ∼50% more likely both to cause total and severe hypoglycemia than were insulin sensitization with metformin and rosiglitazone, with a suggestion of worse cv outcome (bari 2d study group et al., 2009). |
| PubMedID- 21970938 | Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk. |
| PubMedID- 24265250 | We investigated the relation between diabetic autonomic neuropathy (dan) and left ventricular (lv) function in 59 patients with type 2 diabetes mellitus (t2dm) free of coronary artery disease (cad) or hypertension. |
| PubMedID- 26268997 | Alterations in lipid transfers to hdl associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23408783 | Combination of peroxisome proliferator-activated receptor alpha/gamma agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion. |
| PubMedID- 22081334 | The objective of this work was to determine the role of tnfalpha-308g/a gene polymorphism in metabolic syndrome (mets) and coronary artery disease (cad) with obesity and type 2 diabetes mellitus (t2dm). |
Page: 1 2